US2015238253A1PendingUtilityA1

Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation

Assignee: MEDTRONIC ARDIAN LUXEMBOURGPriority: Dec 31, 2008Filed: Mar 3, 2015Published: Aug 27, 2015
Est. expiryDec 31, 2028(~2.4 yrs left)· nominal 20-yr term from priority
A61B 2018/00511A61B 18/02A61B 2018/00404A61B 2018/00577A61B 2017/003A61M 25/0141A61B 18/24A61B 18/1492A61B 2018/00648A61B 2018/00434A61B 90/39A61B 2018/00172A61B 18/18A61B 2018/00791A61N 2007/003A61B 2018/00875A61B 18/1206
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Apparatus, systems, and methods for achieving thermally-induced renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a thermal element to a renal artery via an intravascular path. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers.

Claims

exact text as granted — not AI-modified
1 - 48 . (canceled) 
     
     
         49 . A method for treating hypertension in a patient in need thereof, the method comprising:
 introducing an intravascular treatment device over a guidewire and into a renal artery of the patient, the intravascular treatment device comprising an elongated shaft extending along an axis, and a distal flexure zone carrying at least one electrode;   manipulating the intravascular treatment device so that the distal flexure zone provides contact between a side of the at least one electrode and an interior wall of the renal artery; and   applying energy to form multiple focal lesions on the interior wall of the renal artery, wherein the lesions are circumferentially spaced along a longitudinal axis of the renal artery,   wherein the at least one electrode has a total surface area (TSA) and an active surface area (ASA), and wherein the intravascular treatment device achieves a ratio of ASA to TSA of between 10% and 50%.   
     
     
         50 . The method of  claim 49 , wherein applying energy at least partially modulates neural fibers that contribute to renal function. 
     
     
         51 . The method of  claim 49 , wherein applying energy denervates a kidney of the patient. 
     
     
         52 . The method of  claim 49 , wherein applying energy comprises delivering a monopolar electric field via the at least one electrode. 
     
     
         53 . The method of  claim 49 , wherein applying energy comprises supplying a continuous delivery of radiofrequency (RF) energy to the electrode. 
     
     
         54 . The method of  claim 49 , wherein applying energy comprises exposing the renal artery to a temperature above about 60° C. and less than about 90° C. 
     
     
         55 . The method of  claim 49 , wherein applying energy comprises exposing the renal artery to a temperature above about 60° C. and less than about 80° C. 
     
     
         56 . The method of  claim 49 , wherein the at least one electrode is generally cylindrical. 
     
     
         57 . The method of  claim 49 , wherein the one or more thermal heating effects comprise thermal ablation of tissue on the interior wall of the renal artery. 
     
     
         58 . The method of  claim 49 , wherein introducing an intravascular treatment device into a renal artery of the patient comprises routing the intravascular treatment device through a 6 French guide catheter. 
     
     
         59 . The method of  claim 49 , wherein the intravascular treatment device further comprises a temperature sensor located proximate to the at least one electrode. 
     
     
         60 . The method of  claim 49 , wherein the at least one electrode comprises multiple electrodes. 
     
     
         61 . The method of  claim 49 , further comprising delivering a thermal fluid into the renal artery. 
     
     
         62 . The method of  claim 61 , wherein the thermal fluid comprises saline. 
     
     
         63 . The method of  claim 49 , wherein each of the lesions covers approximately 20 percent to 50 percent of a circumferential area surrounding the renal artery. 
     
     
         64 . The method of  claim 49 , wherein each of the lesions covers approximately 20 percent to 30 percent of a circumferential area surrounding the renal artery. 
     
     
         65 . The method of  claim 49 , further comprising monitoring feedback and altering treatment delivered to the renal artery in response to the feedback. 
     
     
         66 . The method of  claim 49 , wherein the intravascular treatment device comprises a catheter apparatus.

Join the waitlist — get patent alerts

Track US2015238253A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.